About Acurian
Acurian is a company based in Horsham (United States) founded in 1998 was acquired by PPD in August 2013. Acurian has raised $27 million across 1 funding round from investors including Merck, J P Morgan and PPD. Acurian offers products and services including Patient Recruitment and Integrated Network. Acurian operates in a competitive market with competitors including Elligo, Velocity Clinical Research, CenExel, Wake Research and Inclinix, among others.
- Headquarter Horsham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Global Aes
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acurian
Acurian offers a comprehensive portfolio of products and services, including Patient Recruitment and Integrated Network.
Data-driven strategy for recruiting patients in clinical trials
Manages sites and patients for efficient trial performance
Funding Insights of Acurian
Acurian has successfully raised a total of $27M through 1 strategic funding round. The most recent funding activity was a Series B round of $27 million completed in March 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acurian
Acurian has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, J P Morgan and PPD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment strategies are provided across diverse asset classes and markets.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Pharmaceutical products are manufactured and marketed worldwide.
|
Locked | Locked | Locked |
Investor details for Acurian
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acurian
Investment portfolio details for Acurian
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acurian
Detailed financials for Acurian
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acurian Comparisons
Peer comparison for Acurian
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acurian
Acurian operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elligo, Velocity Clinical Research, CenExel, Wake Research and Inclinix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient recruitment and site activation services are provided by Elligo.
|
|
| Locked | Locked | Locked |
Provider of site management and patient recruitment services
|
|
| Locked | Locked | Locked |
Research site management and patient recruitment services are provided.
|
|
| Locked | Locked | Locked |
Clinical site management, patient recruitment, and retention services are provided.
|
|
| Locked | Locked | Locked |
Customized solutions for clinical trial enrollment are provided.
|
Detailed competitors of Acurian
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acurian
Complete news archive for Acurian
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acurian
Acurian was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Acurian is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
Acurian is a funded company, having raised a total of $27M across 1 funding round to date.
Founded in 1998 and based in Horsham, United States, Acurian operates as a subsidiary of PPD within the clinical research sector. Services focus on patient enrollment and retention for trials, utilizing a database of over 100 million opted-in individuals alongside various recruitment methods. Customized plans are developed to target specific therapeutic areas, supporting faster trial timelines and results-based pricing models.
Acurian's top competitors include Velocity Clinical Research, Elligo and CenExel.
Acurian offers Patient Recruitment and Integrated Network.
Acurian has 5 investors. Key investors include Merck, J P Morgan, PPD, Caisse de depot et placement du Quebec, and ProQuest Investments.